Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Share-based payments (Tables)

v3.25.1
Share-based payments (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangements [Abstract]  
Summary Of Number And Weighted Average Exercise Prices Of Share Options
Set out below are summaries of MIP Grant Options and MIP Performance Options granted under the plan:

2024 2023
Average exercise price per share option (in €) Number of grant options Number of performance options Average exercise price per share option (in €) Number of grant options Number of performance options
As at January 1 0.12  1,329,213  1,329,213  0.12  1,329,213  1,329,213 
Granted during the period —  —  —  —  —  — 
Exercised during the period 0.12  (1,329,213) (1,329,213) —  —  — 
Forfeited during the period —  —  —  —  —  — 
As at December 31 —  —  —  0.12  1,329,213  1,329,213 
Vested and exercisable at December 31 —  —  —  —  1,329,213  1,329,213 
Set out below is a summary of the target number of LTIP Performance Options granted under the plan:
2024
Average exercise price per LTIP Performance Option (in €) Target number of LTIP Performance Options
As at January 1 —  2,220,341 
Granted during the period 0.12  4,035,203 
Exercised during the period 0.12  (341,377)
Forfeited during the period —  (1,181,119)
Cancelled during the period —  — 
As at December 31 0.12  4,733,048 
Vested and exercisable at December 31 —  — 
Summary Of Range Of Exercise Prices Of Outstanding Share Options
LTIP Performance Options outstanding at the end of the reporting period have the following expiry dates and exercise prices:
Options Grant date Vesting date Expiry date Exercise price (in €) Target number of options
December 31, 2024
LTIP Performance Options (2022) April 12, 2023 April 12, 2025 April 12, 2032 0.12  697,845 
LTIP Performance Options (2024)* June 11, 2024 June 11, 2027 June 11, 2034 0.12  4,035,203 
*Service period for this award started on January 1, 2024 for two executives and on June 01, 2024 for one executive.
Disclosure Of Number And Weighted Average Exercise Prices Of Other Equity Instruments
Set out below are summaries of the number of RSUs granted to eligible employees and members of the board of directors under the plan:
2023
Employees Eligible directors
As at January 1 —  — 
Granted during the period 176,952  952,812 
Forfeited during the period —  — 
Vested and issued during the period —  (666,968)
As at December 31 176,952  285,844 
Vested and exercisable at December 31 —  — 

2024
Employees Eligible directors
As at January 1 176,952  285,844 
Granted during the period 645,548  632,412 
Forfeited during the period (48,681) — 
Vested and issued during the period (24,109) (285,844)
As at December 31 749,710  632,412 
Vested and exercisable at December 31 —  —